{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T10:09:02Z","timestamp":1767002942008,"version":"3.48.0"},"reference-count":0,"publisher":"Edizioni Internazionali srl, Divisione EDIMES Edizioni Medico-Scientifiche","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infez Med"],"published-print":{"date-parts":[[2025,12,1]]},"DOI":"10.53854\/liim-3304-4","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T10:06:24Z","timestamp":1767002784000},"source":"Crossref","is-referenced-by-count":0,"title":["Administration of antivirals, IL-6 inhibitors, monoclonal neutralizing antibodies and systemic corticosteroids in acute SARS-CoV-2 infection do not reduce the subsequent burden of Long-COVID symptoms"],"prefix":"10.53854","volume":"33","member":"31840","published-online":{"date-parts":[[2025,12,1]]},"container-title":["Infezioni in Medicina"],"original-title":[],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T10:06:26Z","timestamp":1767002786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.infezmed.it\/media\/journal\/Vol_33_4_2025_4.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,1]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.53854\/liim-3304-4","relation":{},"ISSN":["1124-9390","2532-8689"],"issn-type":[{"value":"1124-9390","type":"print"},{"value":"2532-8689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}